CAS Medical Systems (CASM) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss) income	-1.6M
Less income from discontinued operations
Loss from continuing operations	-3.5M
Depreciation and amortization	754.93K
Stock compensation	583.76K
Amortization of gain on sale and leaseback	-100.98K
Deferred income taxes	-1.02M
Accounts receivable	-332.49K
Inventories	234.3K
Other current assets	103.56K
Accounts payable and accrued expenses	-336.44K
Income taxes payable
Net cash (used in) provided by operating activities of continuing operations	-3.8M
Expenditures for property and equipment	-1.02M
Purchase of intangible assets	-70.56K
Net cash used in investing activities of continuing operations	2.1M
Proceeds from note payable
Repayments of note payable	-171.2K
Repayments under line-of-credit	0
Repayments of long-term debt	-7.28M
Deferred financing costs
Proceeds from sale of preferred stock, net
Proceeds from issuance of common stock	42.42K
Net cash provided by financing activities of continuing operations	229.19K
Net cash provided by continuing operations	-1.47M
Cash provided by operating activities of discontinued operations	653.65K
Net cash provided by discontinued operations	653.65K
Net change in cash and cash equivalents	-820.12K
Cash and cash equivalents, beginning of period	7.53M
CASH AND CASH EQUIVALENTS, END OF PERIOD	6.71M
Cash paid during the period for interest	588.24K
Cash paid during the period for income taxes, net

Entities mentioned with CASM

View All Entities